Overview

Clinical Trial to Assess Rate of Onset of Bronchodilator Action in Severe Stable Chronic Obstructive Pulmonary Disease (COPD) Patients

Status:
Completed

Trial end date:
2007-08-01

Target enrollment:

Participant gender:

Summary

This trial evaluates the rate of onset of bronchodilator action of aclidinium bromide compared to placebo and tiotropium in patients with severe COPD after a single dose treatment.

Phase:

Phase 3

Details

Lead Sponsor:

AstraZeneca

Treatments:

Bromides
Tiotropium Bromide